These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8856607)

  • 1. The antiphospholipid/cofactor syndromes.
    Alarcón-Segovia D; Cabral AR
    J Rheumatol; 1996 Aug; 23(8):1319-22. PubMed ID: 8856607
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution of Japanese researchers to progress in the study of allergy and collagen disease in the last 100 years: Antiphospholipid syndrome].
    Koike T
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91(9):2630-3. PubMed ID: 12373885
    [No Abstract]   [Full Text] [Related]  

  • 3. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The new face of phospholipid antibodies].
    Vaarala O
    Duodecim; 1993; 109(21):1890-2. PubMed ID: 7743943
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
    Marai I; Tincani A; Balestrieri G; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hughes syndrome/APS. 30 years on, what have we learnt? Opening talk at the 14th International Congress on antiphospholipid antibodies Rio de Janiero, October 2013.
    Hughes GR
    Lupus; 2014 Apr; 23(4):400-6. PubMed ID: 24619623
    [No Abstract]   [Full Text] [Related]  

  • 8. [20th anniversary of the antiphospholipid syndrome].
    Zimmermann-Górska I
    Pol Arch Med Wewn; 2007; 117 Suppl():8-12. PubMed ID: 18778012
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiphospholipid syndromes with anti-human beta 2-glycoprotein I antibodies despite negative reactivity in conventional aPL and LA assays.
    Guérin V; Couchouron A; Vergnes C; Parrens E; Vernhes JP; Constans J; Boisseau M
    Thromb Haemost; 1997 May; 77(5):1037-8. PubMed ID: 9184427
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology of antiphospholipid antibodies.
    de Groot PG; Derksen RH
    Neth J Med; 2004 Sep; 62(8):267-72. PubMed ID: 15588066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta2 glycoprotein 1 and the anti-phospholipid syndrome.
    Keane PA; Ravikumar K; O'shea SI; Cleary PE
    Am J Ophthalmol; 2006 Oct; 142(4):701-2. PubMed ID: 17011877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antiphospholipid wet workshop: 7th International Symposium on Antiphospholipid Antibodies.
    Pierangeli SS; Stewart M; Silva LK; Harris EN
    J Rheumatol; 1998 Jan; 25(1):156-60. PubMed ID: 9458221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiphospholipid syndrome.
    Avcin T; Kveder T; Rozman B
    N Engl J Med; 2002 Jul; 347(2):145-6; author reply 145-6. PubMed ID: 12110749
    [No Abstract]   [Full Text] [Related]  

  • 16. [Potential mechanisms of thrombogenesis in antiphospholipid syndrome].
    Takeya H; Urano H
    Rinsho Ketsueki; 1998 Feb; 39(2):121-3. PubMed ID: 9545818
    [No Abstract]   [Full Text] [Related]  

  • 17. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.
    Bas de Laat H; Derksen RH; de Groot PG
    Clin Immunol; 2004 Aug; 112(2):161-8. PubMed ID: 15240159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
    de Laat B; Mertens K; de Groot PG
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A "primary" antiphospholipid syndrome?
    Asherson RA
    J Rheumatol; 1988 Dec; 15(12):1742-6. PubMed ID: 14552307
    [No Abstract]   [Full Text] [Related]  

  • 20. Hughes syndrome--the syndrome behind the name (otherwise known as antiphospholipid syndrome).
    Hughes GR
    Isr Med Assoc J; 1999 Oct; 1(2):100-3. PubMed ID: 10731307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.